| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
36,310,000 |
| Market
Cap: |
7.71(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$181.44 - $344.06 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Penumbra is a healthcare company. Co.'s team focuses on developing, manufacturing and marketing medical devices. Co.'s neuro products include Penumbra System brand of products that provides a form of mechanical thrombectomy used by physicians to revascularize blood vessels that are blocked by clots in the intracranial vasculature. Co.'s vascular products include the Ruby Coil System that consists of detachable coils and is used in clinical applications such as active extravasations, or the escape of blood into surrounding tissue, selective embolization in patients with visceral aneurysms, embolization in patients with gastrointestinal bleeding, and high flow arterial venous malformations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
9,648 |
11,253 |
66,601 |
132,615 |
| Total Sell Value |
$2,369,902 |
$2,730,189 |
$18,374,208 |
$35,081,574 |
| Total People Sold |
3 |
6 |
8 |
8 |
| Total Sell Transactions |
5 |
10 |
30 |
56 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rothman Lynn |
EVP and Chief Business Officer |
• – – |
2020-07-13 |
4 |
OE |
$3.98 |
$796 |
D/D |
200 |
12,532 |
|
- |
|
| Elsesser Adam |
CEO and President |
• • – |
2020-07-13 |
4 |
AS |
$186.31 |
$1,535,167 |
I/I |
(8,000) |
997,582 |
|
39% |
|
| Orourke Bridget |
Director |
– • – |
2020-07-13 |
4 |
AS |
$192.47 |
$36,377 |
D/D |
(189) |
3,434 |
|
39% |
|
| Wilder Thomas |
Director |
– • – |
2020-07-13 |
4 |
AS |
$192.47 |
$44,268 |
D/D |
(230) |
526 |
|
39% |
|
| Elsesser Adam |
CEO and President |
• • – |
2020-06-11 |
4 |
AS |
$166.66 |
$1,335,062 |
I/I |
(8,000) |
1,005,582 |
|
38% |
|
| Roberts Johanna |
EVP, Gen. Counsel & Secretary |
• – – |
2020-05-15 |
4 |
D |
$171.14 |
$221,626 |
D/D |
(1,295) |
52,761 |
|
- |
|
| Elsesser Adam |
CEO and President |
• • – |
2020-05-11 |
4 |
AS |
$177.05 |
$1,501,356 |
I/I |
(8,000) |
1,013,582 |
|
6% |
|
| Bose Arani |
Chief Innovator |
• • – |
2020-05-07 |
4 |
AS |
$185.07 |
$1,850,700 |
D/D |
(10,000) |
560,662 |
|
16% |
|
| Bose Arani |
Chief Innovator |
• • – |
2020-04-23 |
4 |
AS |
$185.50 |
$1,688,286 |
D/D |
(9,100) |
570,662 |
|
15% |
|
| Bose Arani |
Chief Innovator |
• • – |
2020-04-20 |
4 |
AS |
$185.11 |
$166,599 |
D/D |
(900) |
579,762 |
|
22% |
|
| Kosaraju Sridhar |
President |
• – – |
2020-04-15 |
4 |
AS |
$164.89 |
$423,204 |
I/I |
(2,500) |
155,351 |
|
35% |
|
| Elsesser Adam |
Chief Executive Officer |
• • – |
2020-04-13 |
4 |
AS |
$154.99 |
$1,262,493 |
I/I |
(8,000) |
1,021,582 |
|
42% |
|
| Orourke Bridget |
Director |
– • – |
2020-04-06 |
4 |
AS |
$162.56 |
$7,153 |
D/D |
(44) |
3,623 |
|
43% |
|
| Kosaraju Sridhar |
President |
• – – |
2020-03-16 |
4 |
AS |
$150.00 |
$385,901 |
I/I |
(2,500) |
157,851 |
|
49% |
|
| Elsesser Adam |
Chief Executive Officer |
• • – |
2020-03-09 |
4 |
AS |
$167.94 |
$1,376,096 |
I/I |
(8,000) |
1,029,582 |
|
12% |
|
| Kassing Don W. |
Director |
– • – |
2020-02-24 |
4 |
AS |
$185.79 |
$56,635 |
D/D |
(304) |
1,705 |
|
2% |
|
| Kosaraju Sridhar |
President |
• – – |
2020-02-18 |
4 |
AS |
$189.93 |
$476,761 |
I/I |
(2,500) |
160,351 |
|
-11% |
|
| Leeds Janet |
Director |
– • – |
2020-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
756 |
2,716 |
|
- |
|
| Kassing Don W. |
Director |
– • – |
2020-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
756 |
2,009 |
|
- |
|
| Grewal Harpreet |
Director |
– • – |
2020-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
756 |
13,395 |
|
- |
|
| Wilder Thomas |
Director |
– • – |
2020-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
756 |
756 |
|
- |
|
| Orourke Bridget |
Director |
– • – |
2020-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
756 |
3,667 |
|
- |
|
| Bose Arani |
Chief Innovator |
• • – |
2020-02-11 |
4 |
AS |
$185.30 |
$1,853,000 |
D/D |
(10,000) |
580,662 |
|
-4% |
|
| Sarna Surbhi |
Director |
– • – |
2020-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
756 |
1,791 |
|
- |
|
| Rothman Lynn |
EVP and Chief Business Officer |
• – – |
2020-02-11 |
4 |
AS |
$185.25 |
$926,250 |
D/D |
(5,000) |
12,332 |
|
-4% |
|
706 Records found
|
|
Page 10 of 29 |
|
|
2.88 (1.38%) 
